Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapy

The aim of this study was to evaluate if bone marrow (BM) SUVmax measured on pre-treatment 18F-FDG PET/CT predicts the clinical outcome of locally advanced cervical cancer (LACC). We recruited retrospectively patients with LACC who underwent staging 18F-FDG PET/CT and had baseline blood tests, then...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncoimmunology
Autors principals: Seban, Romain-David, Robert, Charlotte, Dercle, Laurent, Yeh, Randy, Dunant, Ariane, Reuze, Sylvain, Schernberg, Antoine, Sun, Roger, Mignot, Fabien, Terroir, Marie, Schlumberger, Martin, Haie-Meder, Christine, Chargari, Cyrus, Deutsch, Eric
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2019
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6492982/
https://ncbi.nlm.nih.gov/pubmed/31069132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1574197
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars